Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study - Wikidata - awgldk - TriplyDB

Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study

Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study

http://www.wikidata.org/entity/Q34967905

about

Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes Sunlight exposure and cardiovascular risk factors in the REGARDS study: a cross-sectional split-sample analysis.Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment Diabetic nephropathy - complications and treatment.Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.Vitamin D receptor: A novel therapeutic target for kidney diseases.A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes.

P2860

Q26744419-B5F6A536-4A58-4B8B-842D-CE4D26DC59D1 Q33823811-3A84E302-2980-4D81-A2B0-BA93395C6FF5 Q34008136-2F777A10-F75B-4AD8-94FC-D45E28D84C24 Q34228586-CD15E510-83A1-49BE-B0AF-40EFCC44DA0B Q34387952-1B53E09C-3FF6-4CCF-A695-AFD0D55745D1 Q38787036-4B1995CD-2B6D-416B-A3DB-06471DB2174D Q49985993-4C45CF93-142A-4809-BD3E-41DF5728B49A Q55321789-20433E0A-6896-42A2-97B4-F1BB5DB92A46

P2860

Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study

http://www.wikidata.org/entity/Q34967905

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@ast

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@en

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@nl

type

label

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@ast

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@en

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@nl

prefLabel

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@ast

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@en

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@nl

P1433

Q34967905-19965951-42D6-4C42-A0F7-BCAC8AB24B63

P1476

Q34967905-28B6067B-D5E8-45E8-9598-651F1DAF110D

P2093

Q34967905-5AFB2332-05A0-4BF8-A7CF-A36A18541AB3

Q34967905-8FC80D71-8369-4AEF-95C1-0D5FE7C8A27D

Q34967905-944F7251-08D2-4636-9CC6-846F19BD6435

P2860

Q34967905-070337A3-D2DC-413A-B1FB-CC95C9F51557

Q34967905-09A98C65-CCB2-4CEB-88D3-07A0B22CE38A

Q34967905-0FF476F7-56EA-414E-B8D3-5D5BE76E4402

Q34967905-22A130A6-21F6-40D3-855A-A430AE8D39FF

Q34967905-23FC2723-DE1B-49F8-96E2-50B5BCF036AD

Q34967905-25CC3107-1BAF-45CF-B5A9-FAB1AAE285B0

Q34967905-261D8D74-173F-4903-A118-E0F097AD2377

Q34967905-3737675B-CC1B-44C4-B1B6-0B3C567D217A

Q34967905-38C1DFBB-DF8B-458A-8BF7-1989DD370CFC

Q34967905-3F9F3725-46A1-46D8-BB38-6703C8A3447B

P2888

Q34967905-024F16A7-EF1B-486A-96A4-E8FBD5DF2180

P304

Q34967905-7E7A7D45-3DFF-40F3-B19B-B5BFB4923C13

P31

Q34967905-41AD79A8-E3EF-485F-80E4-52DCAAC7D0A4

P356

Q34967905-588F56D2-05AF-44E4-BA63-5E562B348F23

P478

Q34967905-4BDE3DA6-B413-477C-B5AD-8E411D92805B

P50

Q34967905-C08E27D3-0D71-4708-BE1C-8BB76BF77FCB

P577

Q34967905-53A72B53-7F04-4825-93A6-0759AD058E32

P5875

Q34967905-A814F123-492B-401B-8FD9-6130C67E41EE

P6179

Q34967905-6AA8EB7B-0289-4FC3-B4F8-F0C7B5F8F065

P698

Q34967905-71E108E5-B6E5-48A0-B573-29EB5D6DC753

P921

Q34967905-5522519A-1BC1-47DB-AAD8-BF447C68CFE7

P932

Q34967905-7AFEE417-6AC4-4B7E-B815-FAC385A19124

P356

1472-6823-13-33

P1433

BMC Endocrine Disorders

P1476

Evaluating hormonal mechanisms ...... disease: the VALIDATE-D study

@en

P2093

Anand Vaidya

http://www.w3.org/2001/XMLSchema#string

Jenifer M Brown

http://www.w3.org/2001/XMLSchema#string

Kristina Secinaro

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D and Hypertension: Current Evidence and Future Directions

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy

Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans

Preventing microalbuminuria in type 2 diabetes.

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.

P2888

1472-6823-13-33

P304

33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6823-13-33

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Williams

P577

2013-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256097877

http://www.w3.org/2001/XMLSchema#string

P6179

1023544403

http://www.w3.org/2001/XMLSchema#string

P698

23971740

http://www.w3.org/2001/XMLSchema#string

P921

P932

3765219

http://www.w3.org/2001/XMLSchema#string